Skip to content. | Skip to navigation

News
>
Article | Prefilled Syringes & Parenteral Manufacturing

Article | Prefilled Syringes & Parenteral Manufacturing

Medium: Drug Development and Delivery
Author: Bernd Stauss, SVP Production/Engineering

A Rise in Biologics & Improved Technology Give Pharma Reasons to Consider Parenteral Delivery

Parenteral is one of the most commonly used routes of drug administration. A steady rise in the development and availability of parenteral drugs has resulted in the increasing demand for advanced drug delivery devices that promise cost containment as well as ease of administration. Prefilled syringes are one of the most rapidly expanding segments of the injectable drug delivery devices market. There are several benefits of prefilled syringes over traditional delivery systems: improved safety, ease of administration, accurate dosing, and reduced risk of contamination. These advantages form the basic foundation for the success of prefilled syringes and are likely to continue driving the market during the forecast period.

Technical advances in the sector, rapid growth in the biologics market, and the growing preference for self-administration using autoinjectors, prefilled syringes, and pen injectors are the key factors boosting the global market for prefilled syringes. As a result, the global sales of prefilled syringes amounted to $3.5 billion in 2015 and are projected to reach $7.9 billion by 2024.1 In this annual report, Drug Development & Delivery speaks with some of the leading companies in this market to find out about key trends, packaging advancements, safety improvements, and technology developments.
 

Read the full article: 

SPECIAL FEATURE - Prefilled Syringes & Parenteral Manufacturing: A Rise in Biologics & Improved Technology Give Pharma Reasons to Consider Parenteral Delivery

More news